Latest
Cure sells $20M in intellectual property, replaces CEO and CFO
Oxnard-based Cure Pharmaceutical, a drug delivery platform and CBD products company, will be selling a portion of its intellectual property and related assets for $20 million, the company announced July 28. The buyer was a company called TF Tech Ventures, and the deal closed July 22, Cure said in a July 28 filing with the Read More →
